Home Newsletters Extracellular Matrix News Development of a Hybrid Nanoink for 3D Bioprinting of Heterogeneous Tumor Models

Development of a Hybrid Nanoink for 3D Bioprinting of Heterogeneous Tumor Models

0
Scientists reported a hybrid nanoink composed of alginate, gelatin methacryloyl, and cellulose nanocrystal, designed for multinozzle microextrusion 3D printing of tumor models.
[ACS Biomaterials Science & Engineering]
7992332 {7992332:BBBBBBBB} apa 50 1 170951 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
AbstractGraphical Abstract
Exit mobile version